(Q72394488)
Statements
Subcutaneous therapy with low-dose interleukin-2 plus the neurohormone melatonin in metastatic gastric cancer patients with low performance status (English)
P Lissoni
F Brivio
A Ardizzoia
G Tancini
1 December 1993